Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy. - Wikidata - awgldk - TriplyDB

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

http://www.wikidata.org/entity/Q37024507

about

Exploiting the Metal-Chelating Properties of the Drug Cargo for In Vivo Positron Emission Tomography Imaging of Liposomal Nanomedicines.A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis Nanoparticle Interactions with the Immune System: Clinical Implications for Liposome-Based Cancer Chemotherapy.Applying nanomedicine in maladaptive inflammation and angiogenesis.Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics.Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.Specific Binding of Liposomal Nanoparticles through Inverse Electron-Demand Diels-Alder Click Chemistry.Rethinking cancer nanotheranostics.Computational Analysis on Down-Regulated Images of Macrophage Scavenger Receptor.Imaging-guided revival of nanomedicine?Integrating nanomedicine and imaging.Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic.Reversible Electroporation-Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With 89Zr-Labeled Reporter Nanoparticles.A Dual Bioconjugated Virus-Like Nanoparticle as a Drug Delivery System and Comparison with a pH-Responsive Delivery System.Companion Diagnostic 64Cu-Liposome Positron Emission Tomography Enables Characterization of Drug Delivery to Tumors and Predicts Response to Cancer Nanomedicines.Application of polymersomes engineered to target p32 protein for detection of small breast tumors in mice.Pd nanosheets with their surface coordinated by radioactive iodide as a high-performance theranostic nanoagent for orthotopic hepatocellular carcinoma imaging and cancer therapy.Multi-modal characterization of vasculature and nanoparticle accumulation in five tumor xenograft models Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies Manganese-52: applications in cell radiolabelling and liposomal nanomedicine PET imaging using oxine (8-hydroxyquinoline) as an ionophore Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate

P2860

Q30829681-8C3AED97-E19E-44C4-B280-DBB1F2E57235 Q33615407-5B15437F-5E9D-4151-B659-4A50F22DF45A Q33856678-FAB7DC5A-392C-4E97-B41D-92C98496A738 Q37739064-90E69795-4398-47A5-A195-7D23F88C9DA6 Q38557650-F80E21E9-AC93-4766-9406-E714016170E1 Q38895968-12F4B361-E498-4042-B937-7E197C9A2C87 Q38926681-3400D488-4E49-4FAA-9F40-53F63D2FCBBB Q41269380-ECDAA105-4ACE-4A33-BFCE-2EB67878F353 Q42378064-8ECD65EF-1621-4B77-AB6F-6B43688F7EEB Q42640884-FEA82819-F50F-4F98-91A1-3F4A0013EF1F Q46382974-3765D677-614B-403B-A38E-C30D099C64D5 Q47115988-218A3B58-4E9C-47A3-BBC8-89E564D78177 Q47313459-9787F74F-BDAD-43DA-A53E-7EBAAB793F1D Q48272615-11152C76-0DF7-40F4-8594-0962663802D9 Q52685717-0CFF1FB2-6798-49E4-BD2F-E5E6B2A5C252 Q54236405-E5B3D02E-A27C-4114-966F-7AA187A92CB6 Q55265623-EBB4D875-B23D-447E-B780-155D7FD83A83 Q55267046-8F2BC465-D5F4-413A-82FD-7EE38BEDD3D1 Q55496181-3FD21143-DEB8-4EF9-9890-3D71DD3854E4 Q57181925-339841AC-5F25-4B73-B7D4-ED249B320128 Q58147367-D7023B53-5B49-48D6-BD4D-0C7DEEF417B3 Q58147382-93E11EDA-6876-49A9-AB0E-47B88A2DA6A4 Q58699756-76ABB290-13C6-4F6D-89B1-2C50A23EDB6C

P2860

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

http://www.wikidata.org/entity/Q37024507

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@en

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@nl

type

label

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@en

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@nl

prefLabel

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@en

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

@nl

P1433

Q37024507-D02A12D1-4712-4FC9-ADCF-994AB80E78EE

P1476

Q37024507-309F1963-65FB-4077-BCB8-B92FC6C0D877

P2093

Q37024507-5B689FF7-31E4-4F44-9409-67BC79AD94C4

Q37024507-A5975B31-B146-4A82-B081-6208C09AC2D7

Q37024507-E17F7337-8E9E-4677-A975-4FF0BB6ED920

P2860

Q37024507-07BD5D65-FA72-456E-9EED-E8ECAC5B8558

Q37024507-2050B373-871F-4538-A01A-D6CF40562868

Q37024507-2299309F-9ACE-4DE7-A90C-E06EE3A6B4EE

Q37024507-25D6B7A2-3197-4781-9488-D0B04926DBCD

Q37024507-2E60E148-E160-41BA-A5CF-3EF1B43C596F

Q37024507-372D9FF6-D620-423A-B87F-C50E5159CF2B

Q37024507-3A7A0EBE-DF04-423F-9897-65EF343FC3C2

Q37024507-3DBB882F-77D0-4FC1-B57E-4CE706228B08

Q37024507-4E575718-4B64-4D7D-8063-E8C34F26211F

Q37024507-5948461C-C4B1-4DCB-927E-7D39C6CD4E23

P2888

Q37024507-ADBFF0E6-CA81-4380-B6E9-FE5D2937F926

P304

Q37024507-DA6B8C0B-B2F3-49E0-940A-3FE327511C35

P31

Q37024507-D43E72DB-4CAB-4A0C-AB51-B49926A9F7BA

P356

Q37024507-158C8242-F7FC-41D5-91C6-A874E5907818

P407

Q37024507-B4BC3EA0-4905-4104-AD0B-C963E3DB1926

P478

Q37024507-7208FDBA-8551-469F-9566-BBA1896FA6F8

P50

Q37024507-4705517C-117E-48E3-91DC-0216FC5AC647

Q37024507-49F6191A-A735-4E53-AFB3-0EB4ECECDADA

Q37024507-7C670542-83C1-48E6-863C-9175D5443976

Q37024507-8886B7B3-4814-4EAB-94B1-D6A1757D1F74

Q37024507-A832AE4D-B69D-4C6D-90F4-07C535C821A3

P577

Q37024507-DB3BFC51-4C06-4041-A08E-5133F72CEEF7

P698

Q37024507-2E9DA812-EE3B-4D51-9F46-B6F22A003C83

P932

Q37024507-56ECE89E-0847-4E0D-91F5-6160CF4D1F5A

P356

P1433

Nature Communications

P1476

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy

@en

P2093

Dalya Abdel-Atti

http://www.w3.org/2001/XMLSchema#string

Yiming Zhao

http://www.w3.org/2001/XMLSchema#string

Zahi A Fayad

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in the era of molecular oncology.

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials

Imaging and nanomedicine in inflammatory atherosclerosis

Theranostic nanoparticles

Recent advances with liposomes as pharmaceutical carriers

nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.

Standardized methods for the production of high specific-activity zirconium-89.

State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines

Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.

Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology

P2888

P304

11838

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS11838

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Pérez-Medina

Willem J.M. Mulder

P577

2016-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27319780

http://www.w3.org/2001/XMLSchema#string

P932

4915130

http://www.w3.org/2001/XMLSchema#string